Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency

Bibliographic Details
Main Authors: Martin Adriana, Lavoie Louis, Goetghebeur Mireille, Schellenberg Robert
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Allergy, Asthma & Clinical Immunology
_version_ 1818009322915889152
author Martin Adriana
Lavoie Louis
Goetghebeur Mireille
Schellenberg Robert
author_facet Martin Adriana
Lavoie Louis
Goetghebeur Mireille
Schellenberg Robert
author_sort Martin Adriana
collection DOAJ
first_indexed 2024-04-14T05:41:32Z
format Article
id doaj.art-bf5a55d43c2e4553a4c089bf97650ce6
institution Directory Open Access Journal
issn 1710-1484
1710-1492
language English
last_indexed 2024-04-14T05:41:32Z
publishDate 2012-11-01
publisher BMC
record_format Article
series Allergy, Asthma & Clinical Immunology
spelling doaj.art-bf5a55d43c2e4553a4c089bf97650ce62022-12-22T02:09:26ZengBMCAllergy, Asthma & Clinical Immunology1710-14841710-14922012-11-018Suppl 1A2010.1186/1710-1492-8-S1-A20Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiencyMartin AdrianaLavoie LouisGoetghebeur MireilleSchellenberg Robert
spellingShingle Martin Adriana
Lavoie Louis
Goetghebeur Mireille
Schellenberg Robert
Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
Allergy, Asthma & Clinical Immunology
title Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
title_full Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
title_fullStr Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
title_full_unstemmed Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
title_short Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
title_sort economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
work_keys_str_mv AT martinadriana economicbenefitofsubcutaneousrapidpushversusintravenousimmunoglobulininfusiontherapyinadultpatientswithprimaryimmunedeficiency
AT lavoielouis economicbenefitofsubcutaneousrapidpushversusintravenousimmunoglobulininfusiontherapyinadultpatientswithprimaryimmunedeficiency
AT goetghebeurmireille economicbenefitofsubcutaneousrapidpushversusintravenousimmunoglobulininfusiontherapyinadultpatientswithprimaryimmunedeficiency
AT schellenbergrobert economicbenefitofsubcutaneousrapidpushversusintravenousimmunoglobulininfusiontherapyinadultpatientswithprimaryimmunedeficiency